Goulburn Valley Health, formerly called the Goulburn Valley Base Hospital, is based in the regional city of Shepparton, 2 hours drive north of Melbourne, and caters for the 160,000 people in its region.

During the past decade, Goulburn Valley Health conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 3 clinical trials were completed, i.e. on average, 18.8% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 2 clinical trials were completed. i.e. 18.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Goulburn Valley Health" #1 sponsor was "University of Melbourne" with 2 trials, followed by "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 1 trials sponsored, "Calithera Biosciences, Inc" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "HUYABIO International, LLC." with 1 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Goulburn Valley Health" #1 collaborator was "Middlemore Clinical Trials" with 2 trials as a collaborator, "The Peter Doherty Institute for Infection and Immunity" with 2 trials as a collaborator, "The University of Queensland" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Goulburn Valley Health" are "Colorectal Cancer" (2 trials), "Advanced Renal Cell Carcinoma" (1 trials), "Alzheimer's Disease" (1 trials), "Arterial Thrombosis" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Goulburn Valley Health" in a lesser frequency.

Most popular intervention types in "Goulburn Valley Health" are "Drug" (19 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Abemaciclib" (1 trials), "Acetylsalicylic acid" (1 trials), "Bevacizumab" (1 trials) and "CB-839" (1 trials). Other intervention names were less common.

The vast majority of trials in "Goulburn Valley Health" are 16 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Goulburn Valley Health". undefined are not yet recruiting, 9 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Goulburn Valley Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Goulburn Valley Health, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".